With Revenues and Losses Up, Luminex Sets Date for Report on Corporate Assessment | GenomeWeb

NEW YORK, Oct. 21 (GenomeWeb News) - Luminex today reported an increase in third-quarter revenue and widened net loss.


The company also said it plans to release results of a strategic assessment of the business on Dec. 8.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.